CDH1 and cancer: SATB1 seemed to promote the mesenchymal phenotype of cancer cells by upregulating Vimentin and N-cadherin, as well as downregulating the key epidermal markers Claudin-1, β-catenin and E-cadherin [17]; [Table 1].